首页 > 市场调查报告书 > 食物/饮料

机能性食品

北美维生素 K2 市场预测至 2030 年 - 区域分析 - 按产品、剂型、来源和应用

市场调查报告书

商品编码

1481993

北美维生素 K2 市场预测至 2030 年 - 区域分析 - 按产品、剂型、来源和应用

North America Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 81 Pages | 订单完成后即时交付

价格

简介目录图表

北美维生素K2市场预计将从2022年的6,389万美元成长到2030年的4.9,438亿美元。

CVD 的日益普及推动了北美维生素 K2 市场

心血管疾病（CVD）仍然是一个重大的全球健康问题，近年来其盛行率稳定上升。这种上升是由于人口老化、久坐的生活方式和不良的饮食选择，以及糖尿病、高胆固醇血症和高血压等危险因子的日益普及。据世界卫生组织称，CVD 是死亡的主要原因，全球每年约有 1,790 万人因此死亡。

研究人员正在探索各种预防和治疗方法来对抗心血管疾病。人们感兴趣的领域之一是维生素 K2 在心血管健康中的潜在作用。维生素 K2 或甲基萘醌是维生素 K 的一种形式，与潜在的心血管益处有关。维生素 K2 影响心血管健康的关键机制是其调节钙代谢的作用。动脉钙化是钙沉积在动脉壁中积聚的过程，会导致动脉粥状硬化的发展，而动脉粥状硬化是心血管疾病的一个主要根本原因。研究发现，维生素 K2 透过活化有助于调节钙沉积的蛋白质，在抑制动脉钙化方面发挥重要作用，从而降低动脉粥状硬化和相关心血管疾病的风险。

几项观察性研究探讨了维生素 K2 摄取量与 CVD 结局之间的潜在关联。虽然这些研究无法建立明确的因果关係，但它们提供了有趣的见解。《营养杂誌》的一项研究发现，较高的维生素 K2 摄取量与较低的冠心病死亡率风险有关。此外，维生素 K2 应被视为与生活方式改变一起的潜在辅助治疗或预防措施。这些改变包括采用富含水果、全谷类、蔬菜和瘦蛋白的均衡饮食；保持健康的体重；定期进行体力活动；管理血压和胆固醇水平；以及戒掉吸烟的习惯。因此，CVD 的日益普及正在推动北美维生素 K2 市场的发展。

北美维生素 K2 市场概况

北美维生素 K2 市场分为美国、加拿大和墨西哥。市场的成长归因于心血管疾病盛行率的增加以及成人和新生儿骨质疏鬆症骨变形病例的增加。然而，人们对维生素 K2 益处的认识有限，阻碍了市场的成长。北美市场的成长也归因于维生素 K2 营养补充剂的日益普及。美国占据北美维生素 K2 市场的最大份额。心血管疾病和骨质疏鬆症和关节炎等骨科疾病的盛行率不断增加，增加了对维生素K2 的需求，因为它有助于更好地吸收钙和其他营养物质，并增强心臟和骨骼健康。根据美国疾病管制与预防中心 (CDC) 的数据，2021 年，美国约有 695,000 人死于心臟病，其中冠心病是最常见的心臟病类型，导致该国 375,476 人死亡。此外，该国正在进行产品发布、收购和合併等各种策略发展，也促进了市场的成长。 2022年10月，Kappa Bioscience在美国市场推出了首款有机级维生素K2-MK7，品牌名为K2Vital。它是美国市场上第一个经美国农业部 (USDA) 有机认证的全反式、全生物活性维生素 K2-MK7，用于油性健康应用。因此，心血管疾病和骨科疾病盛行率的上升以及策略合作的增加预计将推动美国维生素 K2 市场的成长。

北美维生素 K2 市场收入及 2030 年预测（百万美元）

北美维生素 K2 市场区隔

北美维生素 K2 市场按产品、剂型、来源、应用和国家细分。

根据产品，北美维生素 K2 市场分为 MK-4、MK-7 和组合药物。 2022 年，MK-7 细分市场占据北美维生素 K2 市场的最大份额。

根据剂型，北美维生素 K2 市场分为胶囊和片剂、粉末和油。 2022 年，粉末细分市场占据北美维生素 K2 市场的最大份额。

根据来源，北美维生素 K2 市场分为天然维生素 K2 和合成维生素 K2。 2022 年，天然维生素 K2 在北美维生素 K2 市场中占据更大份额。

根据应用，北美维生素 K2 市场分为药品、营养保健品和食品等。 2022 年，药品领域占据北美维生素 K2 市场的最大份额。

根据国家/地区，北美维生素 K2 市场分为美国、加拿大和墨西哥。 2022 年，美国将主导北美维生素 K2 市场。

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG 和 Novozymes AS 是北美维生素 K2 市场上的一些领先公司。

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to World Health Organization, CVD is a leading cause of death with ~17.9 million deaths every year globally.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. Vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. Vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the North America vitamin K2 market.

North America Vitamin K2 Market Overview

The North America Vitamin K2 market is segmented into the US, Canada, and Mexico. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market growth in North America is also attributed to the rising adoption of nutraceutical supplements for vitamin K2. The US accounts for the largest share of the vitamin K2 market in North America. The increasing prevalence of cardiovascular diseases and orthopedic disorders, such as osteoporosis and arthritis, has increased the demand for vitamin K2, as it helps in the better absorption of calcium and other nutrients, strengthening cardiac and bone health. According to the Centers for Disease Control and Prevention (CDC), in 2021, ~695,000 people died from heart disease in the US, coronary heart disease being the most common type of heart disease that resulted in the death of 375,476 people in the country. Moreover, various strategic developments such as product launches, acquisitions, and mergers have been taking place in the country, which are contributing to the market growth. In October 2022, Kappa Bioscience launched its first organic grade vitamin K2-MK7 in the US market under the brand name K2Vital. It is the first US Department of Agriculture (USDA) organic-certified all-trans, all-bioactive vitamin K2-MK7 for oil-based health applications in the US market. Therefore, the rising prevalence of cardiovascular diseases and orthopedic disorders, along with an increase in strategic collaboration, is expected to drive the vitamin K2 market growth in the US.

North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

North America Vitamin K2 Market Segmentation

The North America vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the North America vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the North America vitamin K2 market in 2022.

Based on dosage forms, the North America vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the North America vitamin K2 market in 2022.

Based on source, the North America vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the North America vitamin K2 market in 2022.

Based on application, the North America vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the North America vitamin K2 market in 2022.

Based on country, the North America vitamin K2 market is segmented into the US, Canada, and Mexico. The US dominated the North America vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the North America vitamin K2 market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Vitamin K2 Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of CVD
- 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
4.2 Market Restraints
- 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
4.3 Market Opportunities
- 4.3.1 Expansion of Distribution Channel
4.4 Future Trends
- 4.4.1 Regulatory Consideration and Standards
4.5 Impact Analysis:

5. Vitamin K2 Market - North America Market Analysis

5.1 North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

6.1 Overview
6.2 North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
6.3 MK-4
- 6.3.1 Overview
- 6.3.2 MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.4 MK-7
- 6.4.1 Overview
- 6.4.2 MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Combination Drugs
- 6.5.1 Overview
- 6.5.2 Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

7.1 Overview
7.2 North America Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
7.3 Capsules and Tablets
- 7.3.1 Overview
- 7.3.2 Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Powder
- 7.4.1 Overview
- 7.4.2 Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oil
- 7.5.1 Overview
- 7.5.2 Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

8.1 Overview
8.2 North America Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
8.3 Natural
- 8.3.1 Overview
- 8.3.2 Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Synthetic
- 8.4.1 Overview
- 8.4.2 Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

9.1 Overview
9.2 North America Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Pharmaceuticals
- 9.3.1 Overview
- 9.3.2 Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Nutraceuticals and Food
- 9.4.1 Overview
- 9.4.2 Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Vitamin K2 Market - Country Analysis

10.1.1 North America, by Country, 2022 & 2030 (%)
- 10.1.1.1 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1.1 Overview
  - 10.1.1.1.2 US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1.3 US: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.1.4 US: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.1.5 US: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.1.6 US: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.2.1 Overview
  - 10.1.1.2.2 Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.2.3 Canada: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.2.4 Canada: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.2.5 Canada: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.2.6 Canada: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
- 10.1.1.3 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3.1 Overview
  - 10.1.1.3.2 Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3.3 Mexico: North America Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.3.4 Mexico: North America Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
  - 10.1.1.3.5 Mexico: North America Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
  - 10.1.1.3.6 Mexico: North America Vitamin K2 Market, by Application, 2020-2030 (US$ Million)

11. Vitamin K2 Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in Vitamin K2 Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 International Flavors & Fragrances Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Balchem Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BASF SE
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lesaffre et Cie SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Koninklijke DSM NV
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Novozymes AS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Glanbia Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Anderson Global Group LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Vitamin K2 Market Segmentation
Table 2. US: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico: North America Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico: North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico: North America Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Organic Growth Strategies in Vitamin K2 Market
Table 15. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 16. Glossary of Terms, North America Vitamin K2 Market

List Of Figures

Figure 1. North America Vitamin K2 Market Segmentation, By Country
Figure 2. North America Vitamin K2 Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. MK-4: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. MK-7: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Combination Drugs: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 10. Capsules and Tablets: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Powder: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Oil: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 14. Natural: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Synthetic: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. North America Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Pharmaceuticals: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Nutraceuticals and Food: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
Figure 21. North America, by Country, 2022 & 2030 (%)
Figure 22. US: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Canada: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Mexico: North America Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Growth Strategies in Vitamin K2 Market